SCHEMBL6153833

SCHEMBL6153833

OC(c1cccc(-c2nnc(Nc3ccc(Cl)c(Cl)c3)s2)c1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.48
MAPT P10636 2/20 0.43
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
BLM P54132 6/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
PTPN5 P54829 1/20 0.42
POLB P06746 2/20 0.39
P2RY1 P47900 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
DNMT1 P26358 1/20 0.39
HTT P42858 1/20 0.39
DUSP3 P51452 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153621 0.85 GUSB (0.48) GUSBMAPTALDH1A1NPSR1L3MBTL1
SCHEMBL6154319 0.84 ROCK1 (0.45) GUSBMAPTALDH1A1NPSR1L3MBTL1
SCHEMBL6153748 0.82 GUSB (0.54) GUSBMAPTALDH1A1NPSR1L3MBTL1
SCHEMBL6154382 0.82 GUSB (0.40) GUSBMAPTALDH1A1NPSR1L3MBTL1
SCHEMBL6154890 0.80 DHODH (0.44) GUSBMAPTALDH1A1BLMMEN1
SCHEMBL6155161 0.77 GUSB (0.60) GUSBALDH1A1BLMMEN1KMT2A
SCHEMBL6153845 0.76 GUSB (0.48) GUSBMAPTALDH1A1NPSR1L3MBTL1
SCHEMBL6155247 0.75 CFTR (0.47) GUSBMAPTALDH1A1NPSR1BLM
SCHEMBL7148349 0.74 ROCK2 (0.61) GUSBMAPTALDH1A1L3MBTL1BLM
SCHEMBL12336520 0.74 PIK3CD (0.56) MAPTALDH1A1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP GUSB 2466/4885MAPT 3318/4885ALDH1A1 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.